Intellectual Property


Intellectual property is one of the central public policy pillars for the rapidly changing knowledge-based 21st century economy. Intellectual property rights (IPRs) provide an increasingly critical legal and policy toolkit for spurring innovation, stimulating the investments needed to develop and market new innovations, creating jobs and disseminating technology and knowledge in socially beneficial ways.


Promote a robust and effective intellectual property framework worldwide. Provide a forum to encourage a US business consensus on key international policy objectives in intellectual property policy.

Current Priorities

  • International Organizations: Monitor and contribute to the work of international organizations engaged in IP issues to ensure a balanced approach to intellectual property issues that promote innovation.
  • Anti-Counterfeiting and Anti-Piracy: Support and advance the agenda of organizations that ensure intellectual property is respected and protected through anti-counterfeiting and anti-piracy efforts.
  • Trade: Advocate for IP language in trade agreements that establishes a robust and effective intellectual property framework to promote innovation; encourage implementation of such provisions in the Trans-Pacific Partnership, Transatlantic Trade and Investment Partnership and Trade in Services Agreement.




Vice Chair

Sharon Reiche
Corporate Counsel, Global Patents & Policy, Legal Division
Pfizer, Inc.


Michael Michener
Vice President, Product Policy and Innovation
202-617-3159 or

Mia Lauter
Policy & Program Assistant
212-703-5082 or

  • Global Advocacy: Work to ensure that developing and developed countries support and maintain a robust and effective intellectual property environment and public policies that promote and encourage innovation. Protect from disclosure commercially sensitive and proprietary information and documents required by governments under law or regulation.
  • Monitoring and Evaluation of Issues: Monitor and evaluate issues of importance to USCIB members to determine whether further advocacy is required.

Please use the links below to explore recent statements and reports, news stories on USCIB’s website, and media coverage related to our work.

News Stories

USCIB’s Medina Leads Discussion at ChemCon 2016 (10/24/2016) - With companies facing increasing pressure to divulge details of the chemicals in their products, USCIB's Helen Medina spoke at a top chemicals policy conference in Toronto.
Business Presents Views on Health and Innovation to OECD (10/21/2016) - Ahead of a key OECD health ministerial, industry is pushing back against heavy-handed restrictions by governments of foods they deem unhealthy.

Read More

Press Releases

USCIB Welcomes Michael Michener as Vice President of Product Policy and Innovation (2/21/2017) - The United States Council for International Business (USCIB) announced that Michael Michener, a former administrator of the U.S. Foreign Agricultural Service who has also served as a U.S. trade diplomat and association executive, has joined USCIB’s staff as vice president of product policy and innovation.
USCIB Congratulates U.S. on Signature of Anti-Counterfeiting Pact (10/3/2011) - New York, N.Y., October 3, 2011 – The group that represents American business on the global stage welcomed the conclusion of an ambitious international anti-counterfeiting pact between the United States and several leading nations.

Read More

Staff Contact:   Michael Michener

VP, Product Policy and Innovation
Tel: 202.617.3159

Related Content